as on November 4, 2025 at 4:01 pm IST
Day's Low
Day's High
11.68%
Downside
5.98%
Upside
52 Week's Low
52 Week's High
12.77%
Downside
117.39%
Upside
as on November 4, 2025 at 4:01 pm IST
Market Cap
₹27.13 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-21.06
Return on capital employed (ROCE)
0Industry PE ratio
52.45
Beta (LTM)
0.34
P/B Ratio
-8.95
Dividend Yield
0PEG Ratio
175.49
Quarterly Earnings Growth YOY
-315
EPS (TTM)
-0.09
Sector
Healthcare
Book Value
1.41
Technical Analysis
Bearish
View Technical Analysis
as on November 4, 2025 at 4:01 pm IST
Transgene Biotek Ltd in the last 5 years
Lowest (-227.67x)
December 31, 2024
Today (-21.06x)
November 4, 2025
Industry (52.45x)
November 4, 2025
Highest (13.23x)
October 8, 2018
Today’s Price to Earnings Ratio: -21.06x
Compare market cap, revenue, PE, and other key metrics of Transgene Biotek Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 27.13 | -1.87% | 0.96 | -1 | NA | |
| NA | 98.96 | 24.88% | 0.65 | -2 | 46 | |
| NA | 287.54 | 31.9% | 0.53 | 1 | 99 | |
| NA | 213.42 | -5.58% | 0.00 | 3 | 46 | |
| NA | 2,622.26 | 32.58% | 0.67 | 1 | 1,086 |
Search interest for Transgene Biotek Ltd Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:22% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Transgene Biotek Ltd.
Transgene Biotek Ltd’s net profit fell -315% since last year same period to ₹0.43Cr in the Q1 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 39.44% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -0.71 Cr → -0.43 Cr (in ₹), with an average increase of 65.1% per quarter
Against Peers
![]()
In the last 3 years, Vimta Labs Ltd has given 174.9% return, outperforming this stock by 155.6%
Against Peers
![]()
In the last 1 year, Vimta Labs Ltd has given 131.9% return, outperforming this stock by 179.0%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 70.04% of holdings in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 21.68% of holdings in Sep 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 0.12 Cr → 0.05 Cr (in ₹), with an average decrease of 58.3% per quarter
Price Dip
![]()
In the last 7 days, Transgene Biotek stock has moved down by -12.7%
| Organisation | Transgene Biotek Ltd |
| Industry | Healthcare |
| CEO | K Koteswara Rao |
| E-voting on shares | Click here to vote |
Transgene Biotek Ltd share price today stands at ₹3.68 as on at the close of the market. Transgene Biotek Ltd share today touched a day high of ₹3.9 and a low of ₹3.25.
Transgene Biotek Ltd touched a 52 week high of ₹8 and a 52 week low of ₹3.21. Transgene Biotek Ltd share price today i.e. is closed at ₹3.68, which is -54.00% down from its 52 week high and 14.64% up from its 52 week low.
Transgene Biotek Ltd market capitalisation is ₹27.13 Cr as on .
To buy Transgene Biotek Ltd shares, you need to follow these steps:
Transgene Biotek Ltd trading volume is 1.68L as on . This means that 1.68L shares of Transgene Biotek Ltd were bought and sold on the stock market during today's trading session.